Lactose (India) Limited (BOM:524202)

Market Cap	1.26B
Revenue (ttm)	1.16B
Net Income (ttm)	51.63M
Shares Out	12.59M
EPS (ttm)	4.06
PE Ratio	24.61
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	8,390
Average Volume	7,878
Open	95.90
Previous Close	95.90
Day's Range	94.00 - 100.60
52-Week Range	84.27 - 247.40
Beta	0.43
RSI	50.99
Earnings Date	Aug 12, 2025

About Lactose (India)

Lactose (India) Limited engages in the manufacture and trading of pharmaceutical products in India. The company is involved in the production of drugs, medicines, chemicals, foods, etc. It offers lactose monohydrate; dry granulated, film, and lacquer coated tablets; and pharmaceutical products in solid dose forms. In addition, the company provides disaccharide lactulose, an active pharmaceutical ingredient that is used in the treatment of constipation, hepatitis encephalopathy, intestinal microflora, dental care, diabetes, and chronic liver dis...

• Industry: Pharmaceutical Preparations
• Founded: 1991
• Employees: 129
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524202

Financial Performance

In 2024, Lactose (India)'s revenue was 1.16 billion, an increase of 2.20% compared to the previous year's 1.14 billion. Earnings were 51.63 million, a decrease of -23.95%.